4.7 Article

Bile acids increase steroidogenesis in cholemic mice and induce cortisol secretion in adrenocortical H295R cells via S1PR2, ERK and SF-1

Journal

LIVER INTERNATIONAL
Volume 39, Issue 11, Pages 2112-2123

Publisher

WILEY
DOI: 10.1111/liv.14052

Keywords

adrenal steroidogenesis; extracellular signal-regulated kinase; sphingosine 1-phosphate receptor 2; steroidogenic factor 1

Funding

  1. Austrian Science Fund FWF [W 1226] Funding Source: Medline

Ask authors/readers for more resources

Background and Aims Bile acids are now accepted as central signalling molecules for the regulation of glucose, amino acid and lipid metabolism. Adrenal gland cortex cells express the bile acid receptors farnesoid X receptor (FXR), the G protein-coupled bile acid receptor (TGR5) and the sphingosine-1-phosphate receptor 2 (S1PR2). We aimed to determine the effects of cholestasis and more specifically of bile acids on cortisol production. Methods FXR and TGR5 knockout mice and controls were subjected to common bile duct ligation (CBDL) or chenodeoxycholic acid (CDCA) feeding to model cholestasis. Human adrenocortical H295R cells were challenged with bile acids for mechanistic studies. Results We found that CBDL and CDCA feeding increased the levels of corticosterone, the rodent equivalent to human cortisol and mRNA and protein levels of steroidogenesis-related enzymes in adrenals independent of FXR and TGR5. Taurine-conjugated CDCA (TCDCA) significantly stimulated cortisol secretion, phosphorylation of extracellular signal-regulated kinase (ERK) and expression of steroidogenesis-related genes in human adrenocortical H295R cells. FXR and TGR5 agonists failed to induce cortisol secretion in H295R cells. S1PR2 inhibition significantly abolished TCDCA-induced cortisol secretion, lowered phosphorylation of ERK and abrogated enhanced transcription of steroidogenesis-related genes in H295R cells. Likewise, siRNA S1PR2 treatment reduced the phosphorylation of ERK and cortisol secretion. Steroidogenic factor-1 (SF-1) transactivation activity was increased upon TCDCA treatment suggesting that bile acid signalling is linked to SF-1. Treatment with SF-1 inverse agonist AC45594 also reduced TCDCA-induced steroidogenesis. Conclusions Our findings indicate that supraphysiological bile acid levels as observed in cholestasis stimulate steroidogenesis via an S1PR2-ERK-SF-1 signalling pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Biochemistry & Molecular Biology

Bile acids and glucocorticoid metabolism in health and disease

Verena Theiler-Schwetz, Alex Zaufel, Hansjoerg Schlager, Barbara Obermayer-Pietsch, Peter Fickert, Gernot Zollner

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)

Article Endocrinology & Metabolism

Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trial

Felix Aberer, Julia K. Mader, Julia Holzgruber, Christian Trummer, Verena Schwetz, Marlene Pandis, Peter N. Pferschy, Hildegard Greinix, Norbert J. Tripolt, Thomas R. Pieber, Armin Zebisch, Heinz Sill, Albert Woelfler, Harald Sourij

JOURNAL OF DIABETES INVESTIGATION (2019)

Article Nutrition & Dietetics

Effects of vitamin D supplementation on androgens in men with low testosterone levels: a randomized controlled trial

Elisabeth Lerchbaum, Christian Trummer, Verena Theiler-Schwetz, Martina Kollmann, Monika Woelfler, Annemieke C. Heijboer, Stefan Pilz, Barbara Obermayer-Pietsch

EUROPEAN JOURNAL OF NUTRITION (2019)

Article Nutrition & Dietetics

Effects of vitamin D supplementation on metabolic and endocrine parameters in healthy premenopausal women: A randomized controlled trial

Christian Trummer, Verena Theiler-Schwetz, Martina Kollmann, Monika Woelfler, Julia Muenzker, Stefan Pilz, Thomas R. Pieber, Annemieke C. Heijboer, Barbara Obermayer-Pietsch, Elisabeth Lerchbaum

CLINICAL NUTRITION (2020)

Article Nutrition & Dietetics

Effects of Vitamin D Supplementation on Bone Turnover and Bone Mineral Density in Healthy Men: A Post-Hoc Analysis of a Randomized Controlled Trial

Elisabeth Lerchbaum, Christian Trummer, Verena Theiler-Schwetz, Martina Kollmann, Monika Woelfler, Stefan Pilz, Barbara Obermayer-Pietsch

NUTRIENTS (2019)

Article Medicine, General & Internal

Genetic Components of 25-Hydroxyvitamin D Increase in Three Randomized Controlled Trials

Olivia Trummer, Natascha Schweighofer, Christoph W. Haudum, Christian Trummer, Stefan Pilz, Verena Theiler-Schwetz, Martin H. Keppel, Martin Gruebler, Thomas R. Pieber, Wilfried Renner, Barbara Obermayer-Pietsch, Elisabeth Lerchbaum

JOURNAL OF CLINICAL MEDICINE (2020)

Letter Cardiac & Cardiovascular Systems

Letter by Pilz et al Regarding Article, Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China

Stefan Pilz, Verena Theiler-Schwetz, Christian Trummer

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)

Article Multidisciplinary Sciences

Accuracy and stability of an arterial sensor for glucose monitoring in a porcine model using glucose clamp technique

Felix Aberer, Verena Theiler-Schwetz, Haris Ziko, Bettina Hausegger, Iris Wiederstein-Grasser, Daniel A. Hochfellner, Philipp Eller, Georg Tomberger, Martin Ellmerer, Julia K. Mader, Vladimir Bubalo

SCIENTIFIC REPORTS (2020)

Article Endocrinology & Metabolism

Associations of Thyroid Hormones and Resting Heart Rate in Patients Referred to Coronary Angiography

Eva Steinberger, Stefan Pilz, Christian Trummer, Verena Theiler-Schwetz, Markus Reichhartinge, Thomas Benninger, Marlene Pandis, Oliver Malle, Martin H. Keppel, Nicolas Verheyen, Martin R. Grubler, Jakob Voelkl, Andreas Meinitzer, Winfried Marz

HORMONE AND METABOLIC RESEARCH (2020)

Correction Endocrinology & Metabolism

Associations of Thyroid Hormones and Resting Heart Rate in Patients Referred to Coronary Angiography (Sep, 10.1055/a-1232-7292, 2020)

Eva Steinberger, Stefan Pilz, Christian Trummer, Verena Theiler-Schwetz, Markus Reichhartinger, Thomas Benninger, Marlene Pandis, Oliver Malle, Martin H. Keppel, Nicolas Verheyen, Martin R. Gruebler, Jakob Voelkl, Andreas Meinitzer, Winfried Maerz

HORMONE AND METABOLIC RESEARCH (2020)

Article Cell Biology

Recent advances on FXR-targeting therapeutics

Katrin Panzitt, Gernot Zollner, Hanns-Ulrich Marschall, Martin Wagner

Summary: The bile acid receptor FXR is considered as an important drug target for chronic cholestatic and metabolic liver diseases. Activation of FXR in the liver and intestine has different effects on metabolism. There is still debate about whether selective activation of intestinal FXR is advantageous and how to limit FXR activation to reduce side effects.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2022)

Article Gastroenterology & Hepatology

Hepatic farnesoid X receptor is necessary to facilitate ductular reaction and expression of heme biosynthetic genes

Angela E. Dean, Emilian Jungwirth, Katrin Panzitt, Martin Wagner, Sayeepriyadarshini Anakk

Summary: In this study, it was found that hepatic Fxr is necessary for the maintenance of ductular reaction and accumulation of bile plugs. Moreover, Fxr plays an important role in regulating the expression of heme biosynthetic genes. Modulating FXR activity in EPP patients may help alleviate the associated liver disease.

HEPATOLOGY COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

Meta-analysis and Consolidation of Farnesoid X Receptor Chromatin Immunoprecipitation Sequencing Data Across Different Species and Conditions

Emilian Jungwirth, Katrin Panzitt, Hanns-Ulrich Marschall, Gerhard G. Thallinger, Martin Wagner

Summary: The FXR receptor plays an important role in controlling gene regulation in metabolic pathways and is a potential drug target for liver diseases. A meta-analysis of FXR binding data across species revealed modest overlap, with a consolidated murine FXR binding atlas enhancing understanding of FXR signaling capabilities. This could provide a basis for developing new drugs targeting FXR in liver diseases.

HEPATOLOGY COMMUNICATIONS (2021)

Article Endocrinology & Metabolism

Secondary Hyperthyroidism due to an Ectopic Thyrotropin-Secreting Neuroendocrine Pituitary Tumor: A Case Report

Christian Trummer, Hannes Reiher, Verena Theiler-Schwetz, Marlene Pandis, Christian Gstettner, Peter Potzinger, Tilman Keck, Thomas R. Pieber, Sigurd Lax, Johannes Haybaeck, Vinzenz Stepan, Stefan Pilz

EUROPEAN THYROID JOURNAL (2020)

No Data Available